Insulet (PODD) Posts Breakeven Q1

Insulet (NASDAQ: PODD) reported Q1 EPS of $0.00, which may not compare to the analyst estimate of $0.07. Revenue for the quarter came in at $252.3 million versus the consensus estimate of $247.16 million.

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• Movano (MOVE) Misses Q2 EPS by 195c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c